Shot-49-Flu-Virus

Georgia Bio honors Emory drug innovator with Georgia Bio Community Award

January 30th, 2017

Georgia Bio has honored Abel De La Rosa, PhD, chief scientific officer of Drug Innovation Ventures at Emory (DRIVE) and the Emory Institute for Drug Development (EIDD) with a 2017 Community Award.


vlcsnap-5897981

NPR’s Closer look examines DRIVE and EIDD

04/02/2016

David Perryman of Drug Innovation Ventures at Emory (DRIVE) and the Emory Institute for Drug Development discusses the institute and how it ranks nationwide.


vlcsnap-5897981

DRIVE CEO George Painter hiking in Death Valley

03/31/2016

DRIVE CEO George Painter hiking in Death Valley, California- pictured in Spring, 2016 furthering DRIVE’s mission by bridging the Valley of Death.



IconZirus2

Emory Scientists Developing Drugs To Treat Zika Virus

February 19th, 2016

More than 20 scientists with two drug development groups at Emory University are working to develop a treatment for the Zika virus.


Shot-49-Flu-Virus

Drug development experts at Emory join fight against Zika virus

February 17, 2016

Drug Innovation Ventures at Emory (DRIVE) and the Emory Institute for Drug Development (EIDD) have launched an effort to identify and develop antivirals to treat the infection caused by Zika virus.


Shot-49-HIV

Defense Threat Reduction Agency (DTRA) contract to develop drugs to treat infections caused by emerging and man-made viral threats

Emory University announces the award of a Defense Threat Reduction Agency (DTRA) contract to develop drugs to treat infections caused by emerging and man-made viral threats.


vlcsnap-5897981

International university collaboration to tackle Ross River Virus

December 7, 2015

An international collaboration to discover and develop new therapeutic drugs is set to find new treatments for Ross River Virus.


Shot-49-Flu-Virus

DRIVE and AbbVie research collaboration and licensing agreement

May 12, 2015

Drug Innovation Ventures at Emory (DRIVE) and AbbVie have an ongoing research collaboration and licensing agreement to identify small molecules for the treatment of viral diseases.